Preoperative Fasting Triglyceride-glucose Index as a Predictor of Contralateral New Silent Ischemic Brain Lesions after Carotid Artery Stenting

Yi YANG; Shen SHEN; Mengxia WAN; Yongbo ZHANG

doi:10.12259/j.issn.2095-610X.S20250211

Volume 46 Issue 2

Feb. 2025

Turn off MathJax

Article Contents

Abstract

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2025 > 46(2): 74-79

Yi YANG, Shen SHEN, Mengxia WAN, Yongbo ZHANG. Preoperative Fasting Triglyceride-glucose Index as a Predictor of Contralateral New Silent Ischemic Brain Lesions after Carotid Artery Stenting[J]. Journal of Kunming Medical University, 2025, 46(2): 74-79. doi: 10.12259/j.issn.2095-610X.S20250211

Citation:

Yi YANG, Shen SHEN, Mengxia WAN, Yongbo ZHANG. Preoperative Fasting Triglyceride-glucose Index as a Predictor of Contralateral New Silent Ischemic Brain Lesions after Carotid Artery Stenting[J]. Journal of Kunming Medical University, 2025, 46(2): 74-79. doi: 10.12259/j.issn.2095-610X.S20250211

Citation:

Yi YANG, Shen SHEN, Mengxia WAN, Yongbo ZHANG. Preoperative Fasting Triglyceride-glucose Index as a Predictor of Contralateral New Silent Ischemic Brain Lesions after Carotid Artery Stenting[J]. Journal of Kunming Medical University, 2025, 46(2): 74-79. doi: 10.12259/j.issn.2095-610X.S20250211

PDF( 701 KB)

Preoperative Fasting Triglyceride-glucose Index as a Predictor of Contralateral New Silent Ischemic Brain Lesions after Carotid Artery Stenting

doi: 10.12259/j.issn.2095-610X.S20250211

Department of Neurology，Beijing Friendship Hospital，Capital Medical University，Beijing 100050，China

Received Date: 2024-10-18
Available Online: 2025-01-06
Publish Date: 2025-02-18

Abstract

Abstract

Objective To investigate the predictive value of the preoperative fasting Triglyceride-Glucose index （TyG） for contralateral new silence ischemic brain lesions （CNSIBL） following carotid artery stenting （CAS）. Methods A retrospective study was conducted to analyze the clinical data of 183 patients who underwent carotid CAS. The patients were divided into a CNSIBL group （50 cases） and a non-CNSIBL group （133 cases） based on the occurrence of CNSIBL. Baseline data, laboratory tests, and imaging indicators were collected, and TyG was calculated. Using the occurrence of CNSIBL as the dependent variable, multivariate logistic regression analysis was performed with TyG as the independent variable after controlling for confounding factors, and the predictive value of TyG for CNSIBL post-CAS was evaluated using receiver operating characteristic （ROC） curves. Results （1）The number of patients with a history of diabetes mellitus, as well as systolic and diastolic blood pressure on admission in CNSIBL group were statistically significantly higher than that in non-CNSIBL group（P < 0.05）.（2） Triglyceride （TC） levels were higher in the CNSIBL group compared to the non-CNSIBL group（P < 0.05）; TyG was also higher in the CNSIBL group than in the non-CNSIBL group （P < 0.05）; （3） Multivariate Logistic regression analysis results showed that TyG [a OR = 1.125, 95%CI （1.042−1.214）, P < 0.001]was an independent risk factor for contralateral new silent ischemic brain lesions after carotid artery stenting;（4） The ROC curve suggested that the AUC for TyG predicting contralateral new silent ischemic brain lesions post-CAS was 0.77 [95%CI （0.71−0.84）, P < 0.001], with a cut-off value of 1.93, sensitivity of 86.0%, and specificity of 63.9%. Conclusion TyG is an independent influencing factor for contralateral new silent ischemic brain lesions following carotid artery stenting.
- Carotid artery stenting,
- Contralateral new silence ischemic brain lesions,
- Triglyceride-glucose index,
- Atherosclerosis

FullText(HTML)

References(29)

References

[1]	Ryu J C,Bae J H,Ha S H,et al. In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting[J]. BMC Neurol,2023,23(1):79-88. doi: 10.1186/s12883-023-03110-z
[2]	Gensicke H,Worp H B,Nederkoorn P J,et al. Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk[J]. J Am Coll Cardiol,2015,65(6):521-529. doi: 10.1016/j.jacc.2014.11.038
[3]	Feng Y,Bai X,Zhang X,et al. Risk factors for new ischemic cerebral lesions after carotid artery stenting: A systematic review and meta-analysis[J]. Ann Vasc Surg,2021,77(1):296-305.
[4]	Kim M K,Ahn C W,Kang S,et al. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults[J]. Cardiovasc Diabetol,2017,16(1):108-115. doi: 10.1186/s12933-017-0589-4
[5]	Tahapary D L,Pratisthita L B,Fitri N A,et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Triglyceride/glucose index[J]. Diabetes Metab Syndr,2022,16(8):102581-102586. doi: 10.1016/j.dsx.2022.102581
[6]	da Silva A, Caldas A P S, Hermsdorff H H M,et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care[J]. Cardiovasc Diabetol,2019,18(1):1-8. doi: 10.1186/s12933-019-0806-4
[7]	Bouthillier A, van Loveren H R, Keller J T. Segments of the internal carotid artery: A new classification[J]. Neurosurgery,1996,38(3):432-433.
[8]	Brott T G, Hobson R W, Howard G,et al. CREST Investigators: Stenting versus endarterectomy for treatment of carotid-artery stenosis[J]. N Engl J Med,2010,363(1):11-23. doi: 10.1056/NEJMoa0912321
[9]	Setacci C,Chisci E,Setacci F,et al. Siena carotid artery stenting score: Arisk modeling study for individual patients[J]. Stroke,2010,41(6):1259-1265. doi: 10.1161/STROKEAHA.110.578583
[10]	Elqasass A,Hobeika L E,Al-Dawoud Y,et al. Bilateral internal carotid artery agenesis coexisting with bovine aortic arch: Case report and literature review[J]. Anat Sci Int,2024,9(4):1-10.
[11]	Faggioli G,Ferri M,Rapezzi C,et al. Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy[J]. J Vasc Surg,2009,49(1):80-85. doi: 10.1016/j.jvs.2008.08.014
[12]	Miccichè E,Condello F,Cao D,et al. Procedural embolic protection strategies for carotid artery stenting: current status and future prospects[J]. Expert Rev Med Devices,2023,20(5):373-391. doi: 10.1080/17434440.2023.2198124
[13]	Wang S,Shi J,Peng Y,et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: A real-world single-center study[J]. Cardiovasc Diabetol,2021,20(1):1-10. doi: 10.1186/s12933-020-01183-5
[14]	Lee S H,Kwon H S,Park Y M,et al. Predicting the development of diabetes using the product of triglycerides and glucose: the Chung ju Metabolic Disease Cohort (CMC) study[J]. PLoS ONE,2014,9(2):e90430-e90430. doi: 10.1371/journal.pone.0090430
[15]	Wang F,Han L,Hu D. Fasting insulin,insulin resistance and risk of hypertension in the general population: a meta-analysis[J]. Clin Chim Acta,2017,464(3):57-63.
[16]	Joshua K B, Matthew J B. Atherosclerosis: Pathophysiology of insulin resistance,hyperglycemia,hyperlipidemia,and inflammation[J]. J Diabetes,2020,12(2):102-104. doi: 10.1111/1753-0407.12970
[17]	Reardon C A,Lingaraju A,Schoenfelt K Q,et al. Obesity and insulin resistance promote atherosclerosis through an IFNγ-regulated macrophage protein network[J]. Cell Rep,2018,23(10):3021-3030. doi: 10.1016/j.celrep.2018.05.010
[18]	Kim G R,Choi D W,Nam C M,et al. Synergistic association of high-sensitivity C-reactive protein and body mass index with insulin resistance in non-diabetic adults[J]. Sci Rep,2020,10(1):18417-18425. doi: 10.1038/s41598-020-75390-1
[19]	Jeong S,Lee J H. The verification of the reliability of a triglyceride glucose index and its availability as an advanced tool[J]. Metabolomics,2021,17(11):97-109. doi: 10.1007/s11306-021-01837-9
[20]	Yu H X,Tao L Y,Li Y G,et al. Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression[J]. Cardiovasc Diabetol,2023,22(1):130-139. doi: 10.1186/s12933-023-01847-y
[21]	Luo E,Wang D,Yan G,et al. High triglyceride–glucose index is associated with poor prognosis in patients with acute ST elevation myocardial infarction after percutaneous coronary intervention[J]. Cardiovasc Diabetol,2019,18(1):150-162. doi: 10.1186/s12933-019-0957-3
[22]	Su W Y,Chen S C,Huang Y T,et al. Comparison of the effects of fasting glucose,hemoglobin A1C,and triglyceride glucose index on cardiovascular events in type 2 diabetes mellitus[J]. Nutrients,2019,11(11):2838-2851. doi: 10.3390/nu11112838
[23]	Won K B,Kim Y S,Lee B K,et al. The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics[J]. Medicine,2018,97(21):e10726-e10726 doi: 10.1097/MD.0000000000010726
[24]	Lee S B,Ahn C W,Lee B K,et al. Association between triglyceride glucose index and arterial stiffness in Korean adults[J]. Cardiovasc Diabetol,2018,17(1):41-47. doi: 10.1186/s12933-018-0692-1
[25]	Wang A,Tian X,Zuo Y,et al. Association of triglyceride-glucose index with intra- and extra-cranial arterial stenosis: A combined cross-sectional and longitudinal analysis[J]. Endocrine,2021,74(2):308-317. doi: 10.1007/s12020-021-02794-y
[26]	Liu F,Ling Q,Xie S,et al. Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: A systematic review and exposure-effect meta-analysis[J]. Cardiovasc Diabetol,2023,22(1):111-130. doi: 10.1186/s12933-023-01819-2
[27]	Li J,Dong Z,Wu H,et al. The triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease,regardless of diabetes mellitus and hyperlipidemia[J]. Cardiovasc Diabetol,2023,22(1):224-239. doi: 10.1186/s12933-023-01919-z
[28]	Chen T,Qian Y,Deng X. Triglyceride glucose index is a significant predictor of severe disturbance of consciousness and all-cause mortality in critical cerebrovascular disease patients[J]. Cardiovasc Diabetol,2023,22(1):156-169. doi: 10.1186/s12933-023-01893-6
[29]	Ma X T,Dong L S,Shao Q Y,et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type2 diabetes mellitus and acute coronary syndrome[J]. Cardiovasc Diabetol,2020,19(1):31-45. doi: 10.1186/s12933-020-01006-7

Relative Articles(20)

Relative Articles

[1]	Aiyun WANG, Yuting WANG, Jing CAI, Ruoyan NI, Caiying LUO, Zhuo YU, Peng CHEN. The Role of Intestinal Flora and Its Metabolites in The Development of Atherosclerosis. Journal of Kunming Medical University, 2024, 45(12): 160-166. doi: 10.12259/j.issn.2095-610X.S20241223
[2]	Daiju TAO, Peng CHEN, Yuqing LI, Linyi CHEN, Renhua YANG, Bo HE, Zhiqiang SHEN. Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway. Journal of Kunming Medical University, 2023, 44(10): 18-25. doi: 10.12259/j.issn.2095-610X.S20231019
[3]	Li ZHANG, Yuting WANG, Jianing SHI, Dan YU, Renhua YANG, Zhiqiang SHEN, Jiang LONG, Peng CHEN. Network Pharmacology-based Analysis of the Anti-atherosclerosis Mechanism of Scutellarin and Experimental Validation in Vivo. Journal of Kunming Medical University, 2022, 43(8): 17-27. doi: 10.12259/j.issn.2095-610X.S20220804
[4]	Yanlong LIU, Xuefeng GUANG, Xiaolong YIN, Hailong DAI. Effects of miR-125a-3p on Atherosclerotic Plaque, M1/M2 Macrophages, MMP-9 and VEGF. Journal of Kunming Medical University, 2022, 43(9): 1-6. doi: 10.12259/j.issn.2095-610X.S20220915
[5]	Hai-long DAI, Nan WANG, Xiao-qing CHEN, Zhen-yi HE, Xiao-lan FENG, Xue-feng GUANG. Characteristics of Intestinal Microflora in Patients with Coronary Heart Disease. Journal of Kunming Medical University, 2020, 41(12): 36-41. doi: 10.12259/j.issn.2095-610X.S20201213
[6]	Lan Dan Feng . . Journal of Kunming Medical University,
[7]	Cao Rui . . Journal of Kunming Medical University,
[8]	Pang Xing Mei . . Journal of Kunming Medical University,
[9]	Guan Bing . . Journal of Kunming Medical University,
[10]	Chen Li Ling . . Journal of Kunming Medical University,
[11]	Shen Zhi Qiang . . Journal of Kunming Medical University,
[12]	Shen Zhi Qiang . . Journal of Kunming Medical University,
[13]	Zhu Ya Juan . . Journal of Kunming Medical University,
[14]	Zhang Tao . . Journal of Kunming Medical University,
[15]	Hu Yan Jie . . Journal of Kunming Medical University,
[16]	Wang Ling . The Correlation between Lower Extremity Atherosclerosis and Bone Mineral Density in Type 2 Diabetes Mellitus Patients. Journal of Kunming Medical University,
[17]	. Therapeutic Effect of PAS Combination Therapy on 40 Patients with Atherosclerosis. Journal of Kunming Medical University,
[18]	. Evaluation of Atherosclerosis in Rheumatoid Arthritis Patients with High Lipid Levels by Ultrasonography. Journal of Kunming Medical University,
[19]	Deng Zi Yu . . Journal of Kunming Medical University,
[20]	Qiu Hong Mei . . Journal of Kunming Medical University,